Early safety signals from nivolumab in the adjuvant treatment of real-world melanoma patients derived from the German prospective non-interventional study NICO

R. Gutzmer,M. Weichenthal,T. Eigentler, I. Grimmelmann, T. Sickmann, L. Zimmer, E. Livingstone,S. Ugurel,J. S. Utikal, V. Muller, D. Goppner,R. Herbst, A. Kreuter, C. Pfohler, W. Hollburg, C. Loquai, K. Kahler,P. Mohr,D. Schadendorf

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT(2022)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要